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express Toll-like receptors (TLRs) has raised the possibility
that these cells directly detect and respond to pathogenswith
implications for either direct nociceptor activation or sensiti-
zation. A range of neuronal TLRs have been identified, how-
ever a detailed description regarding the distribution of
expression of these receptors within sub-populations of
sensory neurons is lacking. There is also some debate as to
the composition of the TLR4 receptor complex on sensory
neurons. Here we use a range of techniques to quantify the
expression of TLR4, TLR7 and some associated molecules
within neurochemically-identified sub-populations of trigem-
inal (TG) and dorsal root (DRG) ganglion sensory neurons.
We also detail the pattern of expression and co-expression
of two isoforms of lysophosphatidylcholine acyltransferase
(LPCAT), a phospholipid remodeling enzyme previously
shown to be involved in the lipopolysaccharide-dependent
TLR4 response in monocytes, within sensory ganglia.
Immunohistochemistry shows that both TLR4 and TLR7pref-
erentially co-localize with transient receptor potential valli-
noid 1 (TRPV1) and purinergic receptor P2X ligand-gated
ion channel 3 (P2X3), markers of nociceptor populations,
within both TG and DRG. A gene expression profile shows
that TG sensory neurons express a range of TLR-associated
molecules. LPCAT1 is expressed by a proportion of both
nociceptors and non-nociceptive neurons. LPCAT2
immunostaining is absent from neuronal profiles within both
TGandDRGand is confined to non-neuronal cell types underhttp://dx.doi.org/10.1016/j.neuroscience.2015.09.069
0306-4522/ 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
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686naı¨ve conditions. Together, our results show that nocicep-
tors express the molecular machinery required to directly
respond to pathogenic challenge independently from the
innate immune system.  2015 IBRO. Published by Elsevier
Ltd. All rights reserved.
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Traditionally it is thought that pathogens interact with
sensory neurons through indirect mechanisms involving
the activation of an innate immune response and
production of pro-inﬂammatory mediators (see Ren and
Dubner, 2010 for review). These indirect mechanisms
involve the release of inﬂammatory mediators and the
peripheral sensitization of high-threshold sensory neu-
rons, nociceptors, increasing excitability to threshold
and sub-threshold stimuli and contributing toward the
transition from acute to chronic pain states (for reviews
see Marchand et al., 2005; Ren and Dubner, 2010). A
complex web of interactions between neurons, non-
neuronal cells and immune cells develops to maintain a
state of pain hypersensitivity (Milligan and Watkins,
2009; Austin and Moalem-Taylor, 2010; Grace et al.,
2011; Nicotra et al., 2012). Previous work on the impact
of inﬂammatory mediators on nociceptor sensitization
and pain generation has suggested that the degree of
pain associated with infection is heavily inﬂuenced by
the degree of immune activation (Marchand et al., 2005;
Ren and Dubner, 2010). It is now understood that sensory
neurons can directly detect and respond to pathogenic
challenge independent of the innate immune system.
Toll-like receptors (TLRs) are a family of innate
pattern recognition receptors that detect a wide range of
exogenous pathogenic and endogenous damage-
released ligands. Since the discovery by Wadachi and
Hargreaves (2006) of TLR4 expression on trigeminal sen-
sory neurons, a range of functional TLRs have been
shown to be expressed by neurons in both the peripheral
and central nervous system (Lafon et al., 2006; Mishra
et al., 2006; Wadachi and Hargreaves, 2006; Cameron
et al., 2007; Acosta and Davies, 2008; Barajon et al.,
2009; Ochoa-Cortes et al., 2010; Diogenes et al., 2011;
Ferraz et al., 2011; Qi et al., 2011; Due et al., 2012;
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TLRs in neurons, particularly primary sensory neurons,
has uncovered a potential innate surveillance function
with implications for both the acute nociceptive response
and the maintenance of chronic pain states.
TLR4 and the co-receptor CD14 are expressed on rat
and human transient receptor potential vanilloid 1
(TRPV1)-positive and TRPV1-negative nociceptors
within the trigeminal ganglion (TG) (Wadachi and
Hargreaves, 2006; Diogenes et al., 2011). Activation of
TLR4, by Porphyromonas gingivalis lipopolysaccharide
(LPS), on TG sensory neurons both sensitizes TRPV1
and potentiates capsaicin-induced calcitonin gene-
related peptide (CGRP) release (Diogenes et al., 2011;
Ferraz et al., 2011). A role for TLR4, expressed by TG
neurons, in mediating pain induced by tissue damage
has also been demonstrated (Ohara et al., 2013; Miller
et al., 2014). The activation of TLR4, by Escherichia coli
LPS, on murine dorsal root ganglion (DRG) neurons has
been shown to increase neuronal excitability (Ochoa-
Cortes et al., 2010; Due et al., 2012), nociceptin
expression (Acosta and Davies, 2008) and the myeloid
diﬀerentiation primary response protein 88 (MyD88)-
dependent production of pro-inﬂammatory mediators
(Ochoa-Cortes et al., 2010; Tse et al., 2014a). The ability
of TLRs to inﬂuence the nociceptive response is not lim-
ited to TLR4. Activation of TLR3, 7 and 9 expressed by
DRG neurons induces the production of pro-
inﬂammatory mediators, up-regulates TRPV1 expression
and sensitizes TRPV1 activation (Qi et al., 2011). Activa-
tion of TLR3 and TLR7 induces an itch response (pruritus)
and directly activates DRG nociceptors (Liu et al., 2010,
2012). More recently the activation of TLR7, by endoge-
nous microRNAs, has been shown to rapidly activate
DRG neurons through mechanisms that involve TRPA1
(Park et al., 2014).
In the DRG, the reported percentage of total TLR4-
positive neurons varies widely (28–60%; Acosta and
Davies, 2008; Due et al., 2012; Tse et al., 2014a,b). While
it has been shown that 19% of neurons in the maxillary
region of the TG and 29% of neurons innervating the gin-
givomucosa express TLR4, mainly in small- to medium-
sized neurons (Vindis et al., 2014), there are currently
no quantitative data for TLR4 expression within the TG
as a whole. Previous studies have suggested that the
expression of TLR7 is limited to small/medium sized neu-
rons that express TRPV1 and TRPA1 although no quan-
titative analysis has been performed (Liu et al., 2010; Qi
et al., 2011; Park et al., 2014).
There is also some debate regarding the composition
of the TLR4 receptor complex expressed by sensory
neurons. In innate immune cells a functional TLR4-
signaling complex consists of TLR4, CD14 and myeloid
diﬀerentiation protein (MD)-2 (Akira and Takeda, 2004).
DRG neurons reportedly express CD14 and MD-1
messenger ribonucleic acid (mRNA) and protein but little
MD-2 and no radioprotective 105 (RP105) mRNA or pro-
tein (Acosta and Davies, 2008). Upon activation, neuronal
TLR4 is reported to form an atypical co-receptor complex
with CD-14 and MD-1 (Acosta and Davies, 2008).
MD-1 classically interacts with the TLR4 homolog,RP105 to regulate TLR4 signaling (Ohto et al., 2011).
More recent studies however have shown that DRG neu-
rons do express MD-2 and RP105 mRNA and protein in
addition to MD-1 and CD14 mRNA and protein (Ochoa-
Cortes et al., 2010; Tse et al., 2014a). Additionally it
was shown that the majority of TLR4-positive neurons
co-localize with CD14 and MD-2, rather than MD-1 (Tse
et al., 2014a).
Lysophosphatidylcholine acyltransferase 1 and 2
(LPCAT1 and LPCAT2) are two isoforms of a
phospholipid-modifying enzyme that participate in
membrane remodeling by mediating the acylation of
lysophosphatidylcholine (see Shindou and Shimizu,
2009). The phospholipid/lysophospholipid composition of
cellular membranes aﬀects membrane function, including
lipid raft functions (Stulnig et al., 2001), and therefore may
impact upon multiple cellular signaling pathways including
TLR4 signaling (see Triantaﬁlou et al., 2011). In macro-
phages, LPCAT2 is activated by phosphorylation follow-
ing TLR4-dependent LPS recognition (Morimoto et al.,
2010) and LPCAT activity is essential for the translocation
of TLR4 to lipid rafts and subsequent generation of a
TLR4 signaling response (Jackson et al., 2008). LPCAT1
and LPCAT2 have been identiﬁed in a range of tissues
although a high level of expression has been demon-
strated in lung alveolar cells and immune cells for
LPCAT1 and LPCAT2, respectively (Nakanishi et al.,
2006; Shindou et al., 2007; Morimoto et al., 2010). Both
LPCAT1 and LPCAT2 expression have been demon-
strated in a sub-set of spinal neurons (Okubo et al.,
2012). Whereas LPCAT1 expression is constitutive,
LPCAT2 is an inducible form of the enzyme (Shindou
et al., 2005). Indeed, LPCAT2 is up-regulated in microglia
following nerve injury while LPCAT1 expression remains
unchanged (Okubo et al., 2012). LPCAT2 expression
has also been identiﬁed in peripheral sensory neurons
as well as non-neuronal cells within the DRG following
nerve injury (Hasegawa et al., 2010). While previous stud-
ies have identiﬁed the expression of LPCAT isoforms in
injured DRG neurons, the expression of LPCATs naı¨ve
peripheral sensory neurons and the subsequent role they
might play in the neuronal TLR response is unknown.
While it has been shown that nociceptors express a
range of TLRs, a detailed analysis of TLR expression
within multiple sensory neuron sub-populations has not
been performed, particularly within the TG. A detailed
analysis of TLR4 and TLR7 expression patterns within
primary sensory neurons is a pre-requisite for further
functional analysis of receptor activation. In the current
study we explore the hypothesis that nociceptors
possess the required molecular components to directly
detect and respond to ligands of bacterial, viral and
endogenous origin. Using well-deﬁned neurochemical
markers, we provide a semi-quantitative analysis of the
expression of TLR4 and TLR7 within sensory neuron
sub-populations. We also detail a gene expression
proﬁle of TLR signaling-associated components within
the TG. Lastly, we describe the distribution of
expression of two isoforms of a lysophosphatidylcholine
acyltransferase (LPCAT) enzyme, LPCAT1 and
LPCAT2 within sensory ganglia.
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Materials
All materials, unless otherwise stated, were purchased
from Sigma–Aldrich (Gillingham, UK). All real-time
polymerase chain reaction (qPCR) reagents were
purchased from Life Technologies (Carlsbad, CA, USA).
Animal care
Age-matched, adult male Sprague–Dawley rats
(>3 months of age, 250–350 g, Charles River, UK)
were group-housed in a temperature and humidity-
controlled environment with a 12-h light/dark cycle
(lights on at 8:00 A.M.) with food and water available
ad libitum. All experiments adhered to guidelines
described by Schedule 1 of the UK 1986 Animals
(Scientiﬁc Procedures) Act. A total number of 6 animals
were used in this study: 3 for TLR and LPCAT
immunohistochemistry and 3 for qPCR analysis of TLR-
associated gene expression.
Immunohistochemistry
Indirect single- and dual-labeled immunohistochemistry
(IHC) was performed to determine the distribution of
expression of TLR4, TLR7, LPCAT1 and LPCAT2 and
their co-expression with the functional neurochemical
markers neuroﬁlament 200 (NF200), thermo-transducer
TRPV1 and purinergic receptor P2X3 in the rat TG and
DRG. Adult male Sprague–Dawley rats were euthanized
with a lethal dose of sodium pentobarbital (100 mg/kg)
and animals were conﬁrmed as being dead by
conﬁrming the permanent cessation of the circulation.
Animals were then transcardially perfused with 0.1 M
phosphate-buﬀered saline (PBS, pH 7.4) followed by 4%
paraformaldehyde in 0.1 M phosphate buﬀer (pH 7.4).
TG, L4/L5 DRG, lung and spleen tissues were rapidly
removed and post-ﬁxed in 4% paraformaldehyde (pH
7.4) for 2 h at 4 C then cryoprotected overnight in 20%
sucrose in 0.1 M phosphate buﬀer (pH 7.4) at 4 C.
Tissue samples were snap-frozen in optimal cutting
temperature compound (Tissue Tek, UK) and
sequentially cryo-sectioned at 9 lm (CM1100, Leica
Biosystems, Milton-Keynes, UK). Mounted sections
were washed in PBS and blocked/permeabilized with
donkey serum (10% in PBS, 0.2% Triton-X-100, 0.1%
azide) for 1 h in a humidity chamber at room
temperature. Primary antibodies against TLR4 (1:200,
Abcam, Cambridge, UK), TLR7 (1:500, Novus
Biologicals, Littleton, CO, USA), LPCAT1 (1:200,
ProteinTech, Chicago, IL, USA) or LPCAT2 (1:200,
Novus Biologicals, Littleton, CO, USA) were pooled with
primary antibodies against either NF200 (1:4000,
Sigma–Aldrich, Gillingham, UK), TRPV1 (1:200,
Neuromics, Edina, MN, USA) or P2X3 (1:1000, Novus
Biologicals, Littleton, CO, USA) and incubated with
tissue sections for 24 h, with the exception of TLR4
which required a 48-h incubation, in a humidity chamber
at 4 C. After washing with PBS, tissue sections were
incubated with a combination of species-speciﬁc alexa-
ﬂuor (AF) 488 (10 lg/mL, Life Technologies, Carlsbad,CA, USA), AF555 (10 lg/mL, Life Technologies,
Carlsbad, CA, USA) or AF594 (10 lg/mL, Jackson
ImmunoResearch, West Grove, PA, USA) conjugated
secondary antibodies for 3 h in a dark humidity
chamber at room temperature. After washing with PBS,
tissue sections were incubated with 40,6-diamidino-2-phe
nylindole (DAPI) (100 ng/mL, Sigma–Aldrich,
Gillingham, UK) for 1 h in a humidity chamber at room
temperature. Tissue sections were then mounted in
FluorSave reagent (EMD Millipore, Watford, UK) for
imaging.
A series of control experiments were performed to
verify the speciﬁcity of the antibodies used in this study.
The antibodies/antisera used for the neurochemical
markers have been categorized elsewhere (Vulchanova
et al., 1997; Guo et al., 1999; Michael and Priestley,
1999; Kiasalari et al., 2010). These antibodies/antisera
performed as previously described when used in this
study. Primary rat spleen tissue was used as a positive
control for the TLR and LPCAT2 antibodies because of
the high proportion of immune cells found in the spleen.
Primary rat lung tissue was used as a positive control
for LPCAT1. No blocking peptides were available for the
primary antibodies used in this study. For the TLR anti-
bodies we therefore performed staining on tissue known
to be negative for the antigen in question. Peripheral rat
red blood cells were used as negative controls for the
TLR antibodies. Western blotting performed on whole
TG samples was used to verify the speciﬁcity of the
LPCAT antibodies and both displayed single bands at
the expected weights. To test the speciﬁcity of the sec-
ondary antibodies TG sections were incubated with sec-
ondary antibodies in the absence of primary antibodies.
Unstained TG sections were used to observe any auto-
ﬂuorescence within the tissue. No labeling was observed
under the negative control conditions (control images not
shown).
Image acquisition & analysis
Images were captured using a Nikon Eclipse 80i
epiﬂuorescence microscope equipped with a Nikon DS-
Qi1Mc camera using NIS-Elements software (BR 3.2,
Nikon, New York, NY, USA). All images were taken
using 20X or 60X objectives coupled with a 10X
eyepiece. At least 2000 neuronal proﬁles from each
tissue type and each animal were counted on randomly
chosen tissue sections. Only neuronal proﬁles with a
visible nuclear DAPI counterstain were included in the
counting process. Image analysis and quantiﬁcation
were performed on monochrome images by a single
investigator who was blinded to the slide identity.
Subjective visual criteria were used to determine
positive TLR4/TLR7/LPCAT1 immunoreactivity (IR). A
threshold for positive counting was set using mean
ﬂuorescence intensity units, determined by two
independent investigators for each antibody. Co-
expression of TLR4, TLR7 and LPCAT with phenotypic
markers was determined by positive identiﬁcation of
markers in individual images obtained by switching
between TRITC and FITC ﬁlters. Following identiﬁcation
of positive proﬁles in individual images, co-expression
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expressed as a percentage of target markers
expressing phenotypic markers and vice-versa.TG dissociation
To investigate TLR-associated gene expression in TG
sensory neurons, dissociated TG, rather than whole
tissue samples were used in order to remove the
majority of non-neuronal cells and non-cellular
components. The protocol used for TG dissociation in
this study was adapted from Malin et al. (2007). Brieﬂy,
male Sprague–Dawley rats were euthanized by exposure
to rising concentrations of CO2. Animals were transcar-
dially perfused with ice-cold HBSS (Calcium and
Magnesium-free), TG were rapidly removed and cut into
10–12 small pieces. Tissue was incubated with papain
solution (60 units papain, 1 mg L-cysteine in HBSS) for
20 min at 37 C with gentle mixing halfway. Tissue was
pelleted by centrifugation at 800g for 3 min and the super-
natant discarded. The tissue was resuspended in collage-
nase/dispase solution (12 mg collagenase type II and
14 mg dispase type II in HBSS) and incubated for
20 min at 37 C with gentle mixing halfway. Pre-warmed
trypsin inhibitor (1 mg/mL in HBSS) was added to stop
enzymatic digestion and tissue was then pelleted by cen-
trifugation at 800g for 3 min. Mechanical disruption by trit-
uration with a sterile ﬁre-polished, silicon-coated glass
pipette in pre-warmed L15 medium created a single-cell
suspension which was then passed through a 12.5/28%
Percoll gradient at 1800g for 10 min to yield a neuron-
enriched cell pellet which was immediately processed
for RNA isolation.Fig. 1. TLR4 and TLR7 expression within the TG and DRG. Multiple
neuronal proﬁles display intracellular granular IR for TLR4 within the
TG (A) and DRG (B), arrows show selected examples of positive
neurons. A proportion of non-neuronal cells that were morphologically
identiﬁed as satellite cells also display a positive stain for TLR4 within
both TG and DRG, indicated by asterisks (A, B). Multiple neuronal
proﬁles also display positive IR for TLR7 within the TG (C) and DRG
(D), arrows show selected examples. All non-neuronal cells within the
tissue are negative for TLR7. Scale bar 50 lm.Real-time polymerase chain reaction (qPCR)
Total messenger RNA (mRNA) from dissociated TG
neurons and whole spleen tissue was isolated using
RNAqueous-Micro kit according to the manufacturer’s
instructions. Isolated RNA was treated with DNase I for
20 min at 37 C to remove any genomic DNA
contamination. Total RNA concentration was determined
using a Qubit 2.0 Fluorometer with the Qubit RNA
Assay Kit. Sample purity was assessed using a
nanodrop 2000 (Thermo-Fisher Scientiﬁc, Waltham, MA,
USA). Only samples with a 260/280 ratio of >1.8 were
used for reverse transcription. First-strand cDNA was
synthesized from 100 ng RNA using the SuperScript
VILO cDNA Synthesis Kit which contained SuperScript
III reverse transcriptase (Reaction conditions: 25 C for
10 min, 42 C for 2 h, 85 C for 5 min). cDNA was stored
at 20 C until used for qPCR. Relative quantiﬁcation
was achieved with qPCR using TaqMan Gene
Expression Assays for TLR4 (Rn00569848_m1), MD-1
(Rn01434815_m1), MD-2 (Rn01448830_m1), CD14
(Rn00572656_m1), MyD88 (Rn01640049_m1) and
TRIF-related adapter molecule (TRAM) (Rn02082
474_s1) with glyceraldehyde 3-phosphate dehydrogen
ase (GAPDH, Rn01775763_g1) as the endogenous
control. All qPCR experiments used TaqMan Fast
Advanced Master Mix and were performed in triplicate
on a QuantStudio 12 k Flex system with a Fast 96-wellBlock using 2.5 ng of template cDNA in a total reaction
volume of 10 lL per well. The reaction parameters were
as follows – 50 C for 2 min, 95 C for 20 s, 40 cycles of
95 C for 1 s and 60 C for 20 s. An initial no RT control
for each sample type was performed to assess the
eﬀectiveness of the DNAse treatment used which
returned an undetectable result. No template controls
were also included in every run and returned
undetectable results. A gene expression proﬁle from
each tissue type was created using DCT values, with
GAPDH set at 100. Analysis of gene expression data
between tissue types was performed using the 2DDCT
method (Livak and Schmittgen, 2001) with target gene
expression in each sample normalized against the
endogenous control gene GAPDH.Statistical analysis
Data are displayed as mean ± SEM, n= 3.
Comparisons between groups were made using a
Student’s t-test, as appropriate, performed on IBM
SPSS statistics software version 21.0 (1 animal = 1 unit
for statistical analysis). Diﬀerences were considered
statistically signiﬁcant when p< 0.05.RESULTS
Expression of TLR4 & TLR7 within the adult
mammalian TG & DRG
Indirect single-labeling IHC was used to investigate the
expression of TLR4 and TLR7 within the naı¨ve adult rat
TG and DRG. Multiple neuronal proﬁles displayed
TLR4- and TLR7-IR in the TG and DRG (Fig. 1).
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proportion of non-neuronal cells that were
morphologically identiﬁed as satellite cells (elongated
fusiform cells that envelope neuronal soma) also
expressed TLR4 (Fig. 1A, B). Non-neuronal staining
was diﬀerentiated from neuronal membrane staining by
carefully examining the co-expression patterns with
neuronal markers and also by identifying the non-
neuronal cell nucleus. No overlap of staining with
neuronal markers was observed and clear,
distinguishable nuclei were identiﬁed hence we
characterized this staining as non-neuronal.
TLR4 was expressed by 29.3 ± 3.4% and 32 ± 2.9%
of total sensory neurons in the TG and DRG, respectively.
TLR7 was expressed by 32.4 ± 1.8% and 35 ± 3.9% of
sensory neurons in the TG and DRG, respectively.
There was no signiﬁcant diﬀerence in expression levels
of TLR4 and TLR7 between the TG and DRG (Student’s
t-test). TLR4-/TLR7-IR neurons are expressed as a
percentage of total neuronal proﬁles as deﬁned using a
DAPI counterstain. Rat spleen tissue was used as a
positive control and displayed multiple TLR4- and TLR7-
IR cells, respectively (Fig. 2). Red blood cells were used
as a negative control tissue as they do not express
TLR4 or TLR7. No staining was observed in the
negative control tissue (Fig. 3). Spleen tissue was
stained in the absence of primary antibodies to assess
the speciﬁcity of the secondary antibodies used. No
staining was observed under these conditions (Fig. 4).Fig. 2. Positive control staining of primary antibodies. Multiple
positively stained proﬁles can be identiﬁed for TLR4 (A, B), TLR7
(C, D) and LPCAT2 (E, F) in the spleen and LPCAT1 (G, H) in the
lung. Scale bar 15 lm and 50 lm for spleen and lung images,
respectively.Co-expression of TLR4 & TLR7 with neurochemical
markers of functional sensory neuron populations
Indirect dual-labeling IHC was used to characterize the
degree of co-expression of TLR4 and TLR7 with
neurochemical markers that are indicative of functional
sensory neuron populations within the naı¨ve adult rat
TG and DRG. TLR4-IR was commonly observed in
TRPV1- and P2X3-expressing neurons, respectively
(Fig. 5A–F). However, in contrast to TRPV1 and P2X3,
TLR4 was virtually absent from all NF200-expressing
neurons (Fig. 5G–I).
Similar to TLR4, TLR7-IR was identiﬁed in a large
proportion of TRPV1- and P2X3-expressing neurons,
respectively (Fig. 6A–F). TLR7 and NF200 expression
was also mutually exclusively (Fig. 6G–I). Similar
patterns of co-expression were observed for TLR4 and
TLR7 within the TG and DRG. A full characterization of
TLR4 and TLR7 co-localization within the TG and DRG
is shown in Table 1.
There was a signiﬁcant diﬀerence between TLR4 and
TLR7 in their relative levels of co-expression with the
nociceptor markers used. TLR4 co-localized more
frequently with P2X3-positive neurons compared to
TRPV1-positive neurons (TLR4/TRPV1 co-expression
vs. TLR4/P2X3 co-expression, p< 0.0001 for TG and
DRG, Student’s t-test). In the TG, TLR7 co-localized
more frequently with TRPV1-positive neurons compared
to P2X3-positive neurons (TLR7/TRPV1 co-expression
vs. TLR7/P2X3 co-expression, p< 0.05 for TG,
Student’s t-test.Expression of TLR4 signaling-associated molecules
in TG sensory neurons
We performed qPCR on dissociated TG sensory neurons
in order to create a gene expression proﬁle for TLR4
signaling-associated components. We evaluated the
gene expression of TLR4 and three TLR4 co-receptor
molecules, MD-1, MD-2 and CD14, as well as two
intracellular signaling molecules that represent two
pathways of the TLR4 intracellular signaling cascade,
MyD88 and TRAM. The MyD88 pathway is also
downstream from all other TLRs, with the exception of
TLR3. For reference purposes, we have also included
the pain-associated genes TRPV1, P2X3 and TrkA. The
expression of these target genes relative to the
housekeeping gene GAPDH (set at 100) is shown for
TG sensory neurons (Fig. 7A) and control (spleen
tissue, Fig. 7B), respectively. All target genes are
expressed in TG sensory neurons (CT < 35) albeit at
lower levels than TRPV1, P2X3 and TRKA expression,
respectively (Fig. 7A). Gene expression levels of the
Fig. 3. TLR expression in red blood cells as a negative control. Phase-contrast microscopy was used to identify red blood cells (A). No positive
staining was observed in red blood cells for TLR4 (B) or TLR7 (C) antibodies. Scale bar 50 lm.
Fig. 4. Secondary antibody control staining in spleen tissue. Tissue staining was performed in the absence of primary antibody in order to observe
non-speciﬁcity of secondary antibodies. Minimal levels of non-speciﬁc background staining were observed for Donkey anti-Rabbit AF488 (A),
Donkey anti-Mouse AF555 (B) and Donkey ant-Guinea Pig AF594 (C). Scale bar 50 lm.
Fig. 5. Fluorescence micrograph of rat TG dual-labeled for TLR4-IR (green, A, D, G) plus either TRPV1- (red, B), P2X3- (red, E) or NF200-IR (red,
H). The combined images (C, F, I) show co-localization of TLR4-IR with neurochemical markers. A substantial proportion of TLR4-IR neurons co-
express TRPV1-IR, examples of co-expressing neurons are indicated by ﬁlled arrows (A, B) and by asterisks in the combined image (C). Not all
TRPV1-IR neurons express TLR4, examples indicated by open arrows (A, B, C). A substantial proportion of TLR4-IR neurons also co-express
P2X3-IR, examples of co-expressing neurons are indicated by ﬁlled arrows (D, E) and by asterisks in the combined image (F). Also however, not all
P2X3-IR neurons express TLR4, examples indicated by open arrows (D, E, F). There was minimal co-localization between TLR4-IR and NF200-IR;
examples of co-expressing neurons are indicated by ﬁlled arrows (G, H) and by asterisks in the combined image (I). The majority of NF200-IR
neurons did not express TLR4-IR, examples indicated by open arrows (G, H, I). A similar pattern of expression and co-expression was observed in
the DRG (images not shown). Scale bar 50 lm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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Fig. 6. Fluorescence micrograph of rat TG double labeled for TLR7-IR (green, A, D, G) plus either TRPV1- (red, B), P2X3- (red, E) or NF200-IR
(red, H). The combined images (C, F, I) show co-localization of TLR7-IR with neurochemical markers. A substantial proportion of TLR7-IR neurons
co-express TRPV1-IR, examples of co-expressing neurons are indicated by ﬁlled arrows (A, B) and by asterisks in the combined image (C). Some
neurons expressing low levels of TRPV1-IR neurons do not display TLR7-IR, examples indicated by open arrows (A, B, C). A substantial proportion
of TLR7-IR neurons also co-express P2X3-IR, examples of co-expressing neurons are indicated by ﬁlled arrows (D, E) and by asterisks in the
combined image (F). Also however, not all P2X3-IR neurons display TLR7-IR, examples indicated by open arrows (D, E, F). There was minimal co-
localization between TLR7-IR and NF200-IR; examples of co-expressing neurons are indicated by ﬁlled arrows (G, H) and by asterisks in the
combined image (I). The vast majority of NF200-IR neurons did not express TLR7-IR, examples indicated by open arrows (G, H, I). A similar pattern
of expression and co-expression was observed in the DRG (images not shown). Scale bar 50 lm. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)
Table 1. Summary of TLR4 and TLR7 co-localization with the neurochemical markers TRPV1, P2X3 and NF200 within the naı¨ve adult rat TG and DRG.
Co-expression was expressed as a percentage of target markers expressing phenotypic markers and vice-versa
Neurochemical
label
% of labeled cells that
express TLR4
% of TLR4-positive cells that
express label
% of labeled cells that
express TLR7
% of TLR7-positive cells that
express label
TG
TRPV1 53.7 ± 0.9 57.8 ± 0.9 75.7 ± 2.5 42.6 ± 8.1
P2X3 76.6 ± 0.4 58.2 ± 2 61.6 ± 2.1 33.4 ± 3.1
NF200 3.5 ± 0.7 9.2 ± 1.5 – –
DRG
TRPV1 56.1 ± 1.4 68.2 ± 4.7 78.6 ± 2.6 45.5 ± 10.5
P2X3 81.9 ± 0.6 76.5 ± 2.5 54.8 ± 9.4 32.5 ± 4.8
NF200 4 ± 1.3 6.9 ± 2.1 – –
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were also compared to those of the primary spleen
tissue which is known to contain a broad range of TLR-
expressing immune cells. All genes are expressed at
lower levels in TG sensory neurons than in the spleen
tissue (Fig. 7C). MD-1 was expressed 290.1 ± 36.3-fold
lower in TG sensory neurons compared to primary
spleen tissue although this is not surprising given the
high B lymphocyte content of the spleen tissue (Cesta,
2006). TLR4 gene expression was the most comparable
between the diﬀerent tissue types with a 9.1 ± 1.1-foldlower expression in TG sensory neurons. The remaining
targets were expressed 9.8 ± 2.1 (TRAM), 13 ± 2.1
(MD-2), 24.5 ± 3.1 (MyD88) and 40 ± 8.2 (CD14) fold
lower in TG sensory neurons than the spleen.Expression of LPCAT isoforms in the TG
We performed indirect single- and dual-labeling IHC to
investigate the expression of LPCAT1 and LPCAT2
within the TG and DRG and their co-expression with
neurochemical markers. LPCAT1-IR was identiﬁed in
A B C
Fig. 7. TLR4 signaling-associated component gene expression in dissociated TG sensory neurons (A) and spleen tissue (B) as determined by
qPCR. All genes are expressed relative to GAPDH levels (set at 100). Three pain-associated genes are also included in (A) for reference purposes.
All targets are expressed in sensory neurons (CT < 35). All TLR-associated genes are expressed at noticeably lower levels than each of the three
pain-associated genes, respectively. The diﬀerence in gene expression between TG sensory neurons and spleen tissue is calculated using the
DDCT method (C). All targets are expressed in TG sensory neurons at lower levels compared to spleen tissue. Data are displayed as mean ± S.E.
M., n= 3.
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non-neuronal cells that were morphologically identiﬁed as
satellite cells also displayed weak IR for LPCAT1 (Fig. 8A,
B).
LPCAT1 was expressed by 86.3 ± 4.7%, 67 ± 7.9%
and 47.7 ± 5.3% of TRPV1-, P2X3- and NF200-
expressing neurons, respectively (Fig. 9).
All neuronal proﬁles were negative for LPCAT2 but the
majority of non-neuronal cells displayed strong LPCAT2-
IR (Fig. 8C, D).
Rat lung and spleen tissue were used as positive
control tissues for LPCAT1 and LPCAT2, respectively.
Multiple positively stained cells can be identiﬁed
(Fig. 2E–H). As LPCAT isoforms are expressed acrossFig. 8. LPCAT1 and LPCAT2 expression within the TG and DRG. Approxima
IR, arrows show selected examples (A). A similar pattern of expression wa
morphologically identiﬁed as satellite cells also displayed weak LPCAT1-IR,
above threshold levels within any neuronal proﬁle in either TG or DRG. How
satellite cells, displayed strong LPCAT2-IR within both TG (C) and DRG (D)a range of tissue types we used western blotting to
demonstrate the speciﬁcity of the primary antibodies. A
single band at the expected molecular weight was
identiﬁed for both LPCAT1 and LPCAT2 in the TG,
DRG, cortex and RAW264.7 cells (Fig. 10).DISCUSSION
Previous studies have shown both TLR4 and TLR7 to be
expressed by nociceptors within mammalian sensory
ganglia (Wadachi and Hargreaves, 2006; Liu et al.,
2010; Qi et al., 2011; Due et al., 2012; Park et al.,
2014) however this is the ﬁrst quantitative description of
TLR4 and TLR7 expression within adult mammaliantely half of the total neuronal proﬁles within the TG displayed LPCAT1-
s seen in the DRG (B). A proportion of non-neuronal cells that were
examples indicated by asterisks (A, B). LPCAT2-IR was not detected
ever the majority of non-neuronal cells identiﬁed morphologically as
. Scale bar 50 lm.
Fig. 9. Fluorescence micrograph of rat TG double labeled for LPCAT1-IR (green, A, D, G) plus either TRPV1-(red, B), P2X3-(red, E) or NF200-IR
(red, H). The combined images (C, F, I) show co-localization of LPCAT1-IR with neurochemical markers. LPCAT1-IR shows co-expression with a
substantial proportion of TRPV1-IR neurons, examples of co-expressing neurons are indicated by ﬁlled arrows (A, B) and by asterisks in the
combined image (C). Not all neurons displaying TRPV1-IR neurons express LPCAT1-IR, examples indicated by open arrows (A, B, C). The majority
of LPCAT1-IR neurons also co-express P2X3-IR; examples of co-expressing neurons are indicated by ﬁlled arrows (D, E) and by asterisks in the
combined image (F). A proportion of LPCAT1-IR neurons also co-express NF200-IR, examples of co-expressing neurons are indicated by ﬁlled
arrows (G, H) and by asterisks in the combined image (I). There were also a population of NF200-IR neurons that did not co-express LPCAT1-IR,
examples indicated by open arrows (G, H, I). A similar pattern of expression and co-expression was observed in the DRG (images not shown).
Scale bar 50 lm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 10. Western Blot control for LPCAT isoform expression across multiple tissue types. LPCAT1 (A; 1:1000) and LPCAT2 (B; 1:500) expression in
TG, DRG and cortex. 20 lg of protein was run in each lane. RAW 264.7 cells were used as a positive control. b-III tubulin was used as a loading
control. Images representative of three separate experiments (n= 3).
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Here we show that TLR4 and TLR7 are expressed by
both capsaicin- and ATP-responsive nociceptors due to
a high degree of co-expression with TRPV1 and P2X3,
respectively. We show that dissociated sensory neurons
from the TG express a range of TLR4-associated genes
that are required for a full TLR4 signaling response. We
also show that LPCAT1 and LPCAT2 are expressed
within sensory ganglia although only LPCAT1 displays
neuronal expression in naı¨ve tissue.
Our TLR4 expression data fall within the range of
expression observed in previous studies on DRG tissuesections (28–34% of total neurons; Due et al., 2012;
Tse et al., 2014b). Previous studies have reported that
non-neuronal cells do not express TLR4 (Due et al.,
2012; Tse et al., 2014a) however here we show that a
proportion of satellite cells do indeed display TLR4-IR.
There was no diﬀerence in expression levels of TLR4
and TLR7 between the TG and DRG. Interestingly how-
ever there was a signiﬁcant diﬀerence between TLR4
and TLR7 in their relative levels of co-expression with
the nociceptor markers used. TLR4 co-localized more fre-
quently with P2X3-positive neurons whilst TLR7 co-
localized more frequently with TRPV1-positive neurons.
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unknown although Park et al. (2014) have recently shown
that TLR7 interacts with TRPA1, expressed by a propor-
tion of TRPV1-positive neurons, to directly activate sen-
sory neurons. We found minimal co-localization between
TLR4/TLR7 and NF200 suggesting that TLR4 and TLR7
selectively localize to C-ﬁber nociceptors. Preferential
and direct activation and/or sensitization of C-ﬁber noci-
ceptors by pathogens and damage-released endogenous
molecules (DAMPs) via TLR4 and TLR7 is therefore
potentially possible.
There is now extensive evidence for the involvement
of neuroimmune signaling in the development and
maintenance of chronic pain states (reviewed by Nicotra
et al., 2012). TLRs are an important receptor family
involved in the complex intercellular signaling network
that develops in the setting of chronic inﬂammatory pain.
TLR4 is the most widely studied member of the receptor
family in this regard and it is rapidly up-regulated following
the onset of both inﬂammatory and neuropathic pain
(DeLeo et al., 2004; Raghavendra et al., 2004; Zhao
and Zhang, 2015). TLR4 deletion (Tanga et al., 2005)
and pharmacological inhibition have both been shown to
prevent (Bettoni et al., 2008) and reverse behavioral
hypersensitivity (Hutchinson et al., 2007, 2008, 2010;
Lan et al., 2010; Wu et al., 2010) and decrease the pro-
duction of pro-inﬂammatory mediators in models of neuro-
pathic pain (Tanga et al., 2005; Lan et al., 2010).
Importantly, the involvement of TLR4 in the development
and maintenance of chronic pain has also been demon-
strated in a human model. A low intravenous dose of
LPS sensitized nociceptors to a subsequent capsaicin
challenge and participants experienced an increase in
capsaicin-dependent ﬂare, allodynia and hyperalgesia
however the eﬀect of LPS on neurons in this study is likely
to be mainly indirect (Hutchinson et al., 2013). These ﬁnd-
ings have been extended to include the contribution of
TLR2 and TLR3 to central nervous system preclinical pain
models (Kim et al., 2007; Obata et al., 2008; Mei et al.,
2011). TLR3 (Liu et al., 2012) and TLR7 (Park et al.,
2014) activation has also been shown to directly activate
peripheral sensory neurons in the murine DRG. Early
research in this ﬁeld has focussed mainly on TLR4 how-
ever more TLRs are emerging as important mediators of
pain hypersensitivity. Whilst the role, for example, of
TLR7 in clinical pain models has yet to be studied, periph-
eral blood mononuclear cells from chronic pain patients
display increased responsiveness to TLR7 ligand stimula-
tion, as well as TLR2 and TLR4 (Kwok et al., 2012).
Based on the ﬁndings of the current study, plus others,
it is likely that TLR activation may occur directly and
preferentially on nociceptors without the necessary
intervention of the innate immune system. The ability of
neurons to directly detect and respond to pathogenic
ligands represents a rapid response mechanism that
has signiﬁcant consequences for acute nociceptor
activation, sensitization and altered neuronal/non-
neuronal cell communication. There is also potential for
sensory neurons to detect DAMPs (Goh and Midwood,
2011) and this has been demonstrated in TG (Ohara
et al., 2013) and DRG (Miller et al., 2014; Park et al.,2014) sensory neurons. Following TLR4 activation, for
example, peripheral sensory neurons display increased
excitability (Ochoa-Cortes et al., 2010; Due et al., 2012),
sensitization of TRPV1 and potentiation of TRPV1-
dependent neuropeptide production (Diogenes et al.,
2011; Ferraz et al., 2011). Various pro-inﬂammatory
mediators are also induced downstream from TLR4 acti-
vation (Ochoa-Cortes et al., 2010; Tse et al., 2014a).
Neuronal TLR7 activation induces rapid inward currents
and action potentials to increase neuronal excitability
through mechanisms involving TRPA1 (Liu et al., 2010,
2012; Park et al., 2014). An up-regulation and sensitiza-
tion of TRPV1 and induction of pro-inﬂammatory media-
tors is also observed following neuronal TLR7 activation
(Qi et al., 2011). It is likely that these mediators can fur-
ther act through autocrine and/or paracrine mechanisms
to further alter nociceptive responses and contribute to
the local inﬂammatory response (Opree and Kress,
2000; Sommer and Kress, 2004; Binshtok et al., 2008;
Milligan and Watkins, 2009; Uceyler et al., 2009; Zhang
et al., 2011; Ji et al., 2013).
This study is the ﬁrst to demonstrate a co-localization
between TLR4 and TLR7 with P2X3-expressing neurons.
P2X3 activation, by ATP, induces rapid nociceptor
depolarization which plays a prominent role in the
sensitization of nociceptors and alteration of neuronal/
non-neuronal cell communication following the onset of
neuroinﬂammation (Fabbretti, 2013). It is known that
LPS evokes an up-regulation and sensitization of P2X3
receptors in primary TG neuron cultures although it is
not known whether this is through a direct action on neu-
rons or secondary to the activation of non-neuronal cells
and subsequent release of ATP and inﬂammatory media-
tors (Franceschini et al., 2013). Here we show that a large
proportion of P2X3-positive neurons co-express TLR4
and TLR7 suggesting that bacterial and viral infection,
respectively, could directly modulate P2X3 receptor func-
tion. We suggest that the activation of TLR4 and TLR7
could be suﬃcient to sensitize P2X3 in a similar manner
to that of TLR4-dependent TRPV1 sensitization.
The exact composition of the TLR4 co-receptor
complex that is required for neuronal TLR4 activation
remains unclear. The co-localization of TLR4 with the
co-receptor CD14 has been identiﬁed in capsaicin-
responsive nociceptors within the TG (Wadachi and
Hargreaves, 2006) and the involvement of CD14 in neuro-
pathic pain has been demonstrated (Cao et al., 2009).
However there is conﬂicting evidence as to whether MD-
1 or MD-2 is involved in neuronal TLR4 signaling. In
innate immune cells the TLR4 receptor complex consists
of TLR4, CD14 and MD-2 (Akashi-Takamura and Miyake,
2008). MD-1, a MD-2 homolog, normally forms a complex
with RP105, a TLR4 homolog that lacks an intracellular
Toll/Interleukin-1 receptor (TIR) homology domain
(Medzhitov, 2001). One study has shown that neuronal
TLR4 interacts with MD-1 rather than the conventional
co-receptor MD-2 (Acosta and Davies, 2008). This latter
study also showed lack of MD-2 expression in DRG sen-
sory neurons. However more recent studies have identi-
ﬁed both MD-1 and MD-2 mRNA and protein expression
in DRG nociceptors and shown a preferential co-
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2010; Tse et al., 2014a). The present study shows that
acutely dissociated TG sensory neuron preparations
express TLR4, CD14, MD-1, MD-2, MyD88 and TRAM
mRNA. This in agreement with Tse et al. (2014a) and
Ochoa-Cortes et al. (2010) that sensory neurons express
both MD-1 and MD-2. MyD88 and TRAM are also
expressed by sensory neurons suggesting that both the
MyD88-dependent and MyD88-independent branches of
the TLR4-signaling pathway are available following neu-
ronal TLR4 activation. MyD88-dependent signaling down-
stream of neuronal TLR4 and Interleukin-1b (IL-1b)
receptor activation has been shown (Davis et al., 2006;
Qi et al., 2011; Tse et al., 2014a) however the role of
MyD88-independent signaling in peripheral sensory neu-
rons is yet to be demonstrated. Given that the acutely dis-
sociated sensory ganglia cell preparations used in this
study contain a proportion of non-neuronal cells and we
have shown that a small number of satellite cells display
TLR4-IR it is therefore not possible to directly assign this
expression purely to neurons. However, given the TLR
expression patterns observed in this study as well as
the techniques used when dissociating ganglia we believe
that it is reasonable to suggest that the gene expression is
largely neuronal. It is worth noting that co-receptor com-
ponents, such as MD-2 and CD14, exist in soluble forms
that are secreted from cells to actively participate in the
LPS response (Bazil et al., 1989; Visintin et al., 2001).
Therefore co-receptor components do not necessarily
need to be expressed by neurons to mediate neuronal
TLR4 signaling, a phenomenon which has been demon-
strated in lung epithelial cells (Kennedy et al., 2004).
In monocytes, the group of phospholipid modifying
enzymes known as lysophosphatidylcholine
acyltransferases (LPCAT) is essential for the TLR4
response (Schmid et al., 2003; Jackson et al., 2008).
TLR4 associates with lipid raft membrane domains, in
an LPCAT-dependent manner, in order to activate intra-
cellular signaling cascades (Triantaﬁlou et al., 2002;
Jackson et al., 2008). We have investigated whether
speciﬁc isoforms of this enzyme, LPCAT1 and LPCAT2,
are present in mammalian sensory ganglia and may
therefore be involved in neuronal TLR signaling. Although
multiple studies show that neuronal TLRs are functional, it
is yet to be demonstrated that neuronal TLRs associate
with lipid raft microdomains, as is seen in innate immune
cells, to initiate these responses. Both isoforms are
expressed within sensory ganglia however each displays
a distinct expression pattern within the tissue. Approxi-
mately half of all TG sensory neurons counted in this
study expressed LPCAT1. The expression of LPCAT1
was not exclusive to any one particular sub-population
of sensory neuron; LPCAT1 co-localized to a proportion
of TRPV1-, P2X3- and NF200-positive neurons within
the TG. This suggests that LPCAT1 does not speciﬁcally
mediate TLR4 signaling in sensory neurons and we sug-
gest that LPCAT1 may play a role in more general mem-
brane physiology common to all sensory neuron
populations. Interestingly, we demonstrate a complete
absence of LPCAT2 expression in sensory neurons within
the naı¨ve TG, suggesting little/no LPCAT2 activity in neu-rons under normal conditions. Therefore, based on the
results presented in this study, we cannot suggest a role
for LPCATs in neuronal TLR signaling. It has however
been shown that, unlike LPCAT1, LPCAT2 is an inducible
enzyme and both the expression and PAF synthesizing
activity of LPCAT2 is up-regulated following LPS priming
in monocytes (Shindou et al., 2005). Indeed, the expres-
sion of LPCAT2 has been identiﬁed in sensory neurons
and non-neuronal cells in the DRG and spinal cord follow-
ing nerve injury (Hasegawa et al., 2010; Okubo et al.,
2012). Therefore nerve injury appears suﬃcient to provide
a priming signal that increases LPCAT2 expression within
peripheral and spinal sensory neurons. It is not known
whether LPS exposure is suﬃcient to induce LPCAT2
expression in neurons and understanding this may be
key to uncovering an association of LPCAT2 with neu-
ronal TLR4 signaling.CONCLUSIONS
The full extent of direct pathogen-neuron interactions is
unknown and recently a mechanism for direct activation
of nociceptors by bacterial N-formylated peptides and
the pore-forming toxin a-hemolysin was identiﬁed (Chiu
et al., 2013). Pain experienced in a murine model of Sta-
phylococcus aureus skin infection correlated with bacte-
rial load rather than immune involvement (Chiu et al.,
2013). Therefore, direct pathogen-neuron interactions
may play a more prominent role in the onset of pain
hypersensitivity and may not be as reliant on immune cell
involvement as was previously thought. A growing body of
evidence suggests that TLRs expressed by nociceptors
are able to directly inﬂuence nociceptor function and con-
tribute to a neuroimmune signaling network involving neu-
rons, non-neuronal and immune cells that act both
centrally and peripherally to maintain chronic pain hyper-
sensitivity. In this study we have described in detail the
expression of TLR4, TLR7 and other TLR-associated
molecules within the adult mammalian TG and DRG.
Our results support a mechanism whereby nociceptors
can directly detect and respond to pathogenic challenge
independent of innate immune activation.
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